Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Updated on: February 03,2024

Investigators find disparities in mesothelioma survival due to social determinants, limited access

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainTreatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often af

Updated on:February 03,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on: January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Updated on:January 22,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on: January 30,2024

Depression linked to deadly inflammation in lung cancer patients

by Jeff Grabmeier,The Ohio State UniversityKaplan Meier survival curve for NSCLC patients stratified by NLR systemic inflammation, NLR < 5 and NLR ≥ 5 (n = 184), showing worse survival probab

Updated on:January 30,2024

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on: January 30,2024

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on:January 30,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on: January 02,2024

Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported

byUniversity College LondonAn artist’s depiction of a T cell. Credit: NIAIDResearchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (

Updated on:January 02,2024

Neurofeedback shows promise for addressing 'chemo brain' in pilot study

by University of California, Los AngelesCredit: CC0 Public DomainRestoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental foggine

Updated on: February 03,2024

Neurofeedback shows promise for addressing 'chemo brain' in pilot study

by University of California, Los AngelesCredit: CC0 Public DomainRestoring normal functioning in the brains of cancer patients through neurofeedback could potentially alleviate the mental foggine

Updated on:February 03,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on: January 30,2024

Investigators reveal changes to immune status in patient tumors after radiation

by Roswell Park Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainLittle is known about how radiation therapy to kill cancer cells affects immune cells and other components of patient tumors

Updated on:January 30,2024

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on: March 08,2024

Leukemia, lymphoma squarely in sights of new class of drugs

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers, working with collaborators at the University of Florida, have d

Updated on:March 08,2024

Improving CAR T-cell and monoclonal antibody treatment through epitope editing

by Justin Jackson , Medical XpressCredit: CC0 Public DomainIn a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published inNature, researchers at t

Updated on: January 07,2024

Improving CAR T-cell and monoclonal antibody treatment through epitope editing

by Justin Jackson , Medical XpressCredit: CC0 Public DomainIn a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published inNature, researchers at t

Updated on:January 07,2024

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt

Updated on: February 18,2024

Research unveils genetic characteristics and improved prognosis of triple-negative apocrine carcinoma

by JooHyeon Heo,Ulsan National Institute of Science and TechnologySomatic Point Mutations in TNAC and LK-TNBC. The top 16 significantly mutated genes as determined by the dNdScv algorithm (p &lt

Updated on:February 18,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on: February 01,2024

Researchers share insights on the evolution of proton radiotherapy

by Mass General BrighamCredit: Unsplash/CC0 Public DomainIn a review article published inThe Lancet Oncology, Susu Yan, Ph.D., and Thomas Bortfeld, Ph.D., from the Biophysics Division of MG

Updated on:February 01,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024